Birchview Capital, LP

10% Owner
Birchview Capital, LP
$133,333,000.00
%
COMPANY
SHARES
NET TOTAL
42.03%
BRISTOL-MYERS SQUIBB CO
727,785
$56,039,000.00
7.52%
AZIYO BIOLOGICS INC
1,418,123
$10,026,000.00
6.23%
NEUROCRINE BIOSCIENCES INC
85,240
$8,309,000.00
4.47%
QUIDELORTHO CORP
61,306
$5,958,000.00
2.91%
FOGHORN THERAPEUTICS INC
284,843
$3,874,000.00
2.79%
OVINTIV INC
84,200
$3,721,000.00
2.65%
UNITED THERAPEUTICS CORP
15,000
$3,535,000.00
2.64%
ACADIA PHARMACEUTICALS INC
249,400
$3,514,000.00
2.20%
BIODESIX INC
1,811,412
$2,929,000.00
2.09%
PROTHENA CORP PLC
102,548
$2,784,000.00
1.89%
CONTINENTAL RESOURCES INC
38,600
$2,523,000.00
1.68%
ALBIREO PHARMA INC
113,000
$2,244,000.00
1.68%
ACCELERATE DIAGNOSTICS INC
2,252,388
$2,236,000.00
1.61%
Other
334,000
$2,146,000.00
1.55%
PHREESIA INC
82,700
$2,068,000.00
1.50%
MASIMO CORP
15,280
$1,997,000.00
1.12%
ALKERMES PLC
50,000
$1,490,000.00
0.98%
HARROW HEALTH INC
180,000
$1,310,000.00
0.91%
KARYOPHARM THERAPEUTICS INC
269,332
$1,215,000.00
0.89%
CORCEPT THERAPEUTICS INC
50,000
$1,189,000.00
0.74%
CYTOKINETICS INC
25,000
$982,000.00
0.69%
AVEO PHARMACEUTICALS INC
140,000
$918,000.00
0.64%
PIONEER NATURAL RESOURCES CO
3,800
$848,000.00
0.63%
EQUITRANS MIDSTREAM CORPORATIO
133,050
$846,000.00
0.60%
INHIBRX INC
70,448
$800,000.00
0.51%
INARI MEDICAL INC
10,000
$680,000.00
0.51%
IMMUNOGEN INC
150,000
$675,000.00
0.47%
ARVINAS INC
15,000
$631,000.00
0.46%
CONTRAFECT CORP
200,000
$614,000.00
0.45%
TURNING POINT THERAPEUTICS INC
8,000
$602,000.00
0.43%
CULLINAN MANAGEMENT INC
45,114
$578,000.00
0.41%
APELLIS PHARMACEUTICALS INC
12,000
$543,000.00
0.37%
CHEMOCENTRYX INC
20,000
$496,000.00
0.36%
NEKTAR THERAPEUTICS
128,000
$486,000.00
0.32%
IRHYTHM TECHNOLOGIES INC
4,000
$432,000.00
0.31%
AMICUS THERAPEUTICS INC
38,000
$408,000.00
0.30%
BLUEBIRD BIO INC
98,000
$406,000.00
0.30%
KALVISTA PHARMACEUTICALS INC
40,000
$394,000.00
0.27%
SILK ROAD MEDICAL INC
10,000
$364,000.00
0.25%
XENCOR INC
12,300
$337,000.00